Exchange: NYSE·Updated 07:56 PM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 29

Estimated EPS

$0.83

Reported EPS

$0.86

Surprise

+3.9%

Estimated Rev

$5.36B

Reported Rev

$5.44B

Surprise

+1.44%

$BSX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.62 up 14.81% YoY • Reported revenue of $5.44B up 7.53% YoY • Boston Scientific estimates third quarter 2026 net sales growth of 3 to 5 percent and adjusted EPS of $0.80 to $0.82, with full year 2026 adjusted EPS of $3.28 to $3.32.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.81
--
--
N/A
Q2 '26
$0.83
$0.86
3.90%
BEAT
Q1 '26
$0.79
$0.80
1.51%
BEAT
Q4 '25
$0.78
$0.80
2.56%
BEAT
Q3 '25
$0.71
$0.75
5.29%
BEAT

Advertisement|Remove ads.